Skip to main
ALC
ALC logo

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 30%
Buy 45%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Alcon's positive outlook is supported by its increasing market share in the contact lens segment, which demonstrated year-over-year growth in 4Q24. Additionally, the company's Ocular Health sales reached $416 million, reflecting a 2% growth, while Consumables sales rose to $738 million with a strong 7% increase in the same quarter. Furthermore, Alcon's core operating margin improved to 20.1%, exceeding consensus expectations and marking a 120 basis points increase from the previous year, indicating strong operational efficiency.

Bears say

Alcon faces significant risks related to potential market share losses in both its intraocular lens (IOL) and contact lens markets, which could lead to weaker-than-expected revenue growth. The company's bear case scenario anticipates flat-to low-single digit revenue growth, coupled with minimal operating expense leverage, resulting in slower earnings per share (EPS) growth. Additionally, while Vision Care's operating margin showed improvement, the Surgical segment's operating margin declined, indicating potential challenges within its operational structure.

ALC has been analyzed by 20 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 45% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 20 analysts, ALC has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.24, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.24, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.